Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 13, 2018 - Issue
Submit an article Journal homepage
78
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)

Cristina Esquinas1 Pneumology Department, University Hospital Vall d’Hebron, Barcelona, Spain;2 Public Health, Mental, Maternal and Child Health Nursing Department, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
,
Sonia Serreri3 Università di Sassari, Sassari, Italy
,
Miriam Barrecheguren1 Pneumology Department, University Hospital Vall d’Hebron, Barcelona, Spain
,
Esther Rodriguez1 Pneumology Department, University Hospital Vall d’Hebron, Barcelona, Spain
,
Alexa Nuñez1 Pneumology Department, University Hospital Vall d’Hebron, Barcelona, Spain
,
Francisco Casas-Maldonado4 Pneumology Department, University Hospital San Cecilio, Granada, Spain
,
Ignacio Blanco5 Alpha-1 Antitrypsin Deficiency Spanish Registry (REDAAT), Spanish Society of Pneumology (SEPAR), Barcelona, Spain
,
Pietro Pirina3 Università di Sassari, Sassari, Italy
,
Beatriz Lara6 Coventry and Warwickshire University Hospital, Coventry, UK
&
Marc Miravitlles1 Pneumology Department, University Hospital Vall d’Hebron, Barcelona, Spain;7 CIBER de Enfermedades Respiratorias (CIBERES), SpainCorrespondence[email protected]
 show all
Pages 1001-1007 | Published online: 23 Mar 2018

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Timm Greulich, Anna Albert, Werner Cassel, Tobias Boeselt, Erika Peychev, Andreas Klemmer, Francini Ferreira, Christian Clarenbach, Maria L Torres-Duran, Alice M Turner & Marc Miravitlles. (2022) Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 53-64.
Read now

Articles from other publishers (12)

Weijie Liang, Yuqiong Yang, Shenhai Gong, Mingyuan Wei, Yingfei Ma, Ruipei Feng, Jingyuan Gao, Xiaomin Liu, Fuyi Tu, Wei Ma, Xinzhu Yi, Zhenyu Liang, Fengyan Wang, Lingwei Wang, Dandan Chen, Wensheng Shu, Bruce E. Miller, Ruth Tal-Singer, Gavin C. Donaldson, Jadwiga A. Wedzicha, Dave Singh, Tom M.A. Wilkinson, Christopher E. Brightling, Rongchang Chen, Nanshan Zhong & Zhang Wang. (2023) Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host & Microbe 31:6, pages 1054-1070.e9.
Crossref
Marc Miravitlles, Mike Herepath, Asim Priyendu, Sheetal Sharma, Tatiana Vilchez, Oliver Vit, Michaela Haensel, Virginie Lepage, Helena Gens & Timm Greulich. (2022) Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. European Respiratory Review 31:163, pages 210262.
Crossref
Elizabeth J Becker, Alen Faiz, Maarten van den Berge, Wim Timens, Pieter S Hiemstra, Kristopher Clark, Gang Liu, Xiaohui Xiao, Yuriy O Alekseyev, George O'Connor, Stephen Lam, Avrum Spira, Marc E Lenburg & Katrina Steiling. (2022) Bronchial gene expression signature associated with rate of subsequent FEV 1 decline in individuals with and at risk of COPD . Thorax 77:1, pages 31-39.
Crossref
Igor Barjaktarevic & Marc Miravitlles. (2021) Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis. BMC Pulmonary Medicine 21:1.
Crossref
Iris G.M. Schouten, Marise J. Kasteleyn, Roula Tsonaka, Robert Bals, Alice C. Turner, Ilaria Ferrarotti, Angelo G. Corsico, Beatriz Lara, Marc Miravitlles, Robert A. Stockley & Jan Stolk. (2021) Long-term effect of α 1 -antitrypsin augmentation therapy on the decline of FEV 1 in deficient patients: an analysis of the AIR database . ERJ Open Research 7:3, pages 00194-2021.
Crossref
Peter Lange, Engi Ahmed, Zakaria Mohamed Lahmar, Fernando J. Martinez & Arnaud Bourdin. (2021) Natural history and mechanisms of COPD . Respirology 26:4, pages 298-321.
Crossref
Miriam Barrecheguren, María Torres-Duran, Francisco Casas-Maldonado & Marc Miravitlles. (2021) Implantación en España del nuevo registro internacional de déficit de alfa-1-antitripsina European Alpha-1-Research Collaboration (EARCO). Archivos de Bronconeumología 57:2, pages 81-82.
Crossref
Miriam Barrecheguren, María Torres-Duran, Francisco Casas-Maldonado & Marc Miravitlles. (2021) Spanish implementation of the new international alpha-1 anitrypsin deficiency international registry: The European Alpha-1 Research Collaboration (EARCO). Archivos de Bronconeumología (English Edition) 57:2, pages 81-82.
Crossref
Simone Scarlata, Simona Santangelo, Ilaria Ferrarotti, Angelo Guido Corsico, Stefania Ottaviani, Panaiotis Finamore, Davide Fontana, Marc Miravitlles & Raffaele Antonelli Incalzi. (2020) Electrophoretic α 1 -globulin for screening of α 1 -antitrypsin deficient variants . Clinical Chemistry and Laboratory Medicine (CCLM) 58:11, pages 1837-1845.
Crossref
Ignacio Blanco, Isidro Diego, Patricia Bueno, Sergio Pérez-Holanda, Francisco Casas-Maldonado & Marc Miravitlles. (2020) Prevalence of α 1 -antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review . European Respiratory Review 29:157, pages 200014.
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2019) Treatment with inhaled α1-antitrypsin: a square peg in a round hole?. European Respiratory Journal 54:5, pages 1901894.
Crossref
Miriam Barrecheguren, Robert Bals & Marc Miravitlles. 2019. α 1 -Antitrypsin Deficiency . α 1 -Antitrypsin Deficiency 64 77 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.